Cash Flow Statement

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)Dividends payables Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)

Pharma-Bio Serv (PBSV) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. Growth (1y) (Qtr)
1	Veeva Systems	30.85 Bn	24.28 Bn	622.47 Mn	2.65%
2	BrightSpring Health Services	12.29 Bn	11.41 Bn	482.22 Mn	-76.56%
3	Healthequity	7.80 Bn	7.48 Bn	256.31 Mn	35.37%
4	Hinge Health	4.82 Bn	4.51 Bn	154.23 Mn	166,928.57%
5	Doximity	4.21 Bn	3.46 Bn	125.97 Mn	103.44%
6	Waystar Holding	4.18 Bn	4.03 Bn	268.04 Mn	69.72%
7	10x Genomics	3.78 Bn	3.24 Bn	106.18 Mn	-27.14%
8	Privia Health	2.65 Bn	2.28 Bn	595.71 Mn	23.22%
9	Omnicell	1.95 Bn	1.78 Bn	140.36 Mn	-11.94%
10	Pharma-Bio Serv	-	-	722,374.00	-19.31%

Historic Data

Download Data 🔒

Date	Value
Jan 31, 2026	-19.31%
Oct 31, 2025	39.83%
Jul 31, 2025	-32.44%
Apr 30, 2025	-32.43%
Jan 31, 2025	-27.83%
Oct 31, 2024	359.94%
Jul 31, 2024	0.01%
Apr 30, 2024	0.00%
Jan 31, 2024	-0.01%
Oct 31, 2023	-97.60%
Jul 31, 2023	2.78%
Apr 30, 2023	2.77%
Jan 31, 2023	2.78%
Oct 31, 2022	29.60%
Jul 31, 2022	25.98%
Apr 30, 2022	25.99%
Jan 31, 2022	25.98%
Oct 31, 2021	155.58%
Jul 31, 2021	0.00%
Apr 30, 2021	0.00%
Jan 31, 2021	0.00%
Oct 31, 2020	20.62%
Jul 31, 2020	27.00%
Apr 30, 2020	27.00%
Jan 31, 2020	27.00%
Oct 31, 2019	806.35%
Jul 31, 2019	-48.72%
Apr 30, 2019	-48.72%
Jan 31, 2019	-48.72%
Jul 31, 2018	-11.25%
Apr 30, 2018	-20.41%
Jan 31, 2018	-20.41%
Jul 31, 2017	-10.32%
Apr 30, 2017	0.00%
Jan 31, 2017	0.00%
Oct 31, 2016	211.83%
Jul 31, 2016	5.00%
Apr 30, 2016	-66.31%
Jan 31, 2016	5.00%
Jul 31, 2015	22.81%
Apr 30, 2015	282.74%
Jan 31, 2015	22.81%
Jul 31, 2014	689.47%
Apr 30, 2014	689.47%
Jan 31, 2014	689.47%
Oct 31, 2013	2,054.34%
Jul 31, 2013	0.00%
Apr 30, 2013	-87.38%
Jan 31, 2013	0.00%
Oct 31, 2012	0.00%
Jul 31, 2012	0.00%
Apr 30, 2012	692.52%
Jan 31, 2012	0.00%
Oct 31, 2011	-77.97%
Jul 31, 2011	-55.16%